Drug Profile
Gonadotropin releasing hormone receptor antagonist - Bayer HealthCare
Alternative Names: GnRH antagonistLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Bayer HealthCare
- Class
- Mechanism of Action LHRH receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Uterine leiomyoma
Most Recent Events
- 30 Sep 2014 Phase-I clinical trials in Uterine leiomyoma in Germany (unspecified route)